 |
|
|
| |
Need for Improved HIV Testing Prior to and During Pre-Exposure Prophylaxis with Cabotegravir Long-Acting Injections in Routine Clinical Care in the United States: Low Rates of HIV Tesing
|
| |
| |
25th AIDS 2024 July 20-26 Munich
R. Hsu1,2, L. Brunet3, A. Mills4, K. Mounzer5, M. Wohlfeiler6, K. Frost7, G. Pierone8, M. Sension9, P. Lackey10, J. Fusco3, C. Brown11, V. Vannappagari11, M. Aboud11, P. Budnik12, G. Fusco3
Institutions
1AIDS Healthcare Foundation, New York, United States, 2NYU Langone Medical Center, New York, United States, 3Epividian, Raleigh, United States, 4Men's Health Foundation, West Hollywood, United States, 5Philadelphia FIGHT, Philadelphia, United States, 6AIDS Healthcare Foundation, Miami, United States, 7Foundation for AIDS Research (amfAR), New York, United States, 8Whole Family Health Center, Vero Beach, United States, 9CAN Community Health, Fort Lauderdale, United States, 10Wake Forest University School of Medicine, Winston-Salem, United States, 11ViiV Healthcare, Durham, United States, 12ViiV Healthcare, London, United Kingdom
|
| |
|
|
|
|
|
